Article
IGFBP2 and IGFBP4 interact to activate complement pathway in diabetic kidney disease
13 Jan 2025
Abstract excerpt
BACKGROUND: Diabetic kidney disease (DKD) is the leading cause of chronic kidney disease globally. Recent research has identified insulin-like growth factor-binding proteins 2 (IGFBP2) and 4 (IGFBP4) as potential biomarkers for DKD. Overactivation of the complement pathway in DKD remains poorly understood. METHODS: experiments to investigate the roles of IGFBP2, IGFBP4, and the complement pathway in DKD. RESULTS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
